TLRY logo

Tilray Brands Inc. (TLRY)

$2.35

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on TLRY

Market cap

$347247813

EPS

-14.58

P/E ratio

--

Price to sales

0.56

Dividend yield

--

Beta

2.048327

Price on TLRY

Previous close

$2.34

Today's open

$2.32

Day's range

$2.30 - $2.37

52 week range

$2.30 - $15.70

Profile about TLRY

CEO

Irwin D. Simon

Employees

2650

Headquarters

Leamington, ON

Exchange

Nasdaq Global Select

Shares outstanding

147787523

Issue type

Common Stock

TLRY industries and sectors

Healthcare

Pharmaceuticals

News on TLRY

Tilray Brands stock has crashed to a record low: is this fallen angel a buy?

Tilray Brands stock extended its sell-off this week, sinking to a record low as concerns about the company intensified. The shares fell to $2.34, leaving them down 74% so far this year, 55% over the past six months, and 98% over the past five years.

news source

Invezz • Nov 17, 2026

news preview

Why Didn't Tilray Brands Make a Bid for Aurora Cannabis?

Tilray has been aggressively pursuing acquisitions in recent years. Its focus has largely been on loading up on craft brewers in the U.S. market.

news source

The Motley Fool • Nov 16, 2026

news preview

Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club

A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings, Tastings and Behind-The-Scenes Access A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings, Tastings and Behind-The-Scenes Access

news source

GlobeNewsWire • Nov 11, 2026

news preview

Does Marijuana Rescheduling Really Help Tilray's Stock?

Rescheduling marijuana to a lower level makes the substance easier to research and results in lower tax bills for companies. Tilray, however, is a Canadian producer and won't directly see any benefits from rescheduling.

news source

The Motley Fool • Nov 10, 2026

news preview

Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track?

Tilray is consolidating its operations in Canada to simplify its business and achieve cost savings. The company announced new guidance for adjusted EBITDA that is slightly higher at the low end than before.

news source

The Motley Fool • Nov 9, 2026

news preview

Tilray Brands, Inc. (TLRY) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Tilray Brands (TLRY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

news source

Zacks Investment Research • Nov 5, 2026

news preview

Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth

Consolidation of Foss Cultivation and Pre-roll Production into Optimized Masson and Cayuga Facilities Expected to Generate Approximately US$10 Million in Annualized Cost Savings Higher Cultivation Yields and Expected Reestablishment of EU-GMP Certification Strengthen Tilray's Canadian Cannabis Platform and Position the Business for Continued Growth in Canada, International Markets, and Future U.S. Medical Cannabis Markets When Permissible Tilray Raises Fiscal 2027 Adjusted EBITDA Guidance to $70 Million–$75 Million, Increasing the Lower End of the Range NEW YORK and LONDON and LEAMINGTON, Ontario, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company with leading positions across cannabis, beverage, hospitality and wellness, today announced plans to consolidate its Canadian cannabis operations, transitioning cultivation and pre-roll production from its Foss facility in Fenwick, Ontario to its Masson, Quebec and Cayuga, Ontario facilities. This strategic initiative is expected to generate approximately US$10 million in annualized cost savings by the end of fiscal 2028.

news source

GlobeNewsWire • Nov 2, 2026

news preview

Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink?

Tilray reported record quarterly revenue of $257.1 million. Cannabis revenue declined 13% despite strong international growth.

news source

The Motley Fool • Nov 1, 2026

news preview

Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing

Tilray Brands has shifted from a marijuana company to a global brand manager across marijuana, beverages, and wellness. The company's fiscal first quarter 2027 earnings highlight just how much the business has changed.

news source

The Motley Fool • Nov 1, 2026

news preview

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis

Canopy Growth (CGC -4.34%) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.

news source

The Motley Fool • Oct 30, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Tilray Brands Inc.

Open an M1 investment account to buy and sell Tilray Brands Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in TLRY on M1